Literature DB >> 8687397

Characterization of the inhibitory effects of bile acids on very-low-density lipoprotein secretion by rat hepatocytes in primary culture.

Y Lin1, R Havinga, I J Schippers, H J Verkade, R J Vonk, F Kuipers.   

Abstract

In this study the effects of bile acids and other organic anions on the secretion of very-low-density lipoproteins (VLDLs) were evaluated in rat hepatocytes in primary culture. Incubation of cells with portal blood concentrations (10-200 microM) of bile acids resulted in dose-dependent suppression of secretion of VLDL-associated [3H]triglyceride (TG) formed from [3H]glycerol, and also of TG mass. The degree of the inhibition was highly correlated with intracellular bile acid concentration. Prolonged incubation with 100 microM extracellular taurocholic acid (TC) decreased the secretion of [3H]TG and TG mass to 35% and 50% of the controls respectively. Cellular content of mass and of [3H]TG during prolonged incubation with TC were about 20% and 60% higher than the controls respectively. The inhibitory effect remained for at least 24 h in the presence of TC without altering VLDL-lipid and VLDL-apolipoprotein compositions or the size distribution of the particles. Secretion of apoB-100 and of apoB-48 was inhibited to a similar extent. Cells largely lost their capacity to accumulate bile acids intracellularly after 48 h in culture. In these cells TC was unable to exert its suppressive effects. Taurine and glycine conjugates of all common bile acids were capable of suppressing [3H]TG secretion. Trihydroxylated (cholic acid) and various dihydroxylated (deoxycholic, chenodeoxycholic and ursodeoxycholic acids) bile acids had similar capacities in this respect, suggesting that their common sterol-3 alpha-OH structure is required for the suppressive effect. Neither non-bile acid organic anions, e.g. bilirubin ditaurate and dibromosulphthalein, nor dianionic bile acid metabolites, e.g. sulphated taurolithocholic acid and lithocholate-3-O-glucuronide, showed any effect on [3H]TG secretion. These results indicate that bile acids might play a physiological role in regulating VLDL production by the liver, especially in the postprandial state when their enterohepatic circulation is stimulated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8687397      PMCID: PMC1217381          DOI: 10.1042/bj3160531

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  46 in total

1.  Postprandial serum bile acids in healthy man. Evidence for differences in absorptive pattern between individual bile acids.

Authors:  B Angelin; I Björkhem
Journal:  Gut       Date:  1977-08       Impact factor: 23.059

2.  The binding of detergents to lipophilic and hydrophilic proteins.

Authors:  A Helenius; K Simons
Journal:  J Biol Chem       Date:  1972-06-10       Impact factor: 5.157

3.  Bile acids in portal blood of fats fed different diets and cholestyramine. Bile acids and steroids 189.

Authors:  T Cronholm; J Sjövall
Journal:  Eur J Biochem       Date:  1967-11

Review 4.  Secretion of biliary lipids from the hepatocyte.

Authors:  M P Marzolo; A Rigotti; F Nervi
Journal:  Hepatology       Date:  1990-09       Impact factor: 17.425

5.  Synthesis and secretion of rat albumin in vivo, in perfused liver, and in isolated hepatocytes. Effects of hypophysectomy and growth hormone treatment.

Authors:  R C Feldhoff; J M Taylor; L S Jefferson
Journal:  J Biol Chem       Date:  1977-06-10       Impact factor: 5.157

6.  Prostaglandins suppress VLDL secretion in primary rat hepatocyte cultures: relationships to hepatic calcium metabolism.

Authors:  O G Björnsson; J D Sparks; C E Sparks; G F Gibbons
Journal:  J Lipid Res       Date:  1992-07       Impact factor: 5.922

7.  Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat.

Authors:  D M Heuman; A S Mills; J McCall; P B Hylemon; W M Pandak; Z R Vlahcevic
Journal:  Gastroenterology       Date:  1991-01       Impact factor: 22.682

8.  Dynamics of the enterohepatic circulation of bile acids. Postprandial serum concentrations of conjugates of cholic acid in health, cholecystectomized patients, and patients with bile acid malabsorption.

Authors:  N F LaRusso; M G Korman; N E Hoffman; A F Hofmann
Journal:  N Engl J Med       Date:  1974-10-03       Impact factor: 91.245

9.  Effects of tauroursodeoxycholic acid on cytosolic Ca2+ signals in isolated rat hepatocytes.

Authors:  U Beuers; M H Nathanson; J L Boyer
Journal:  Gastroenterology       Date:  1993-02       Impact factor: 22.682

10.  Regulation of apoB secretion from HepG2 cells: evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge.

Authors:  K M Cianflone; Z Yasruel; M A Rodriguez; D Vas; A D Sniderman
Journal:  J Lipid Res       Date:  1990-11       Impact factor: 5.922

View more
  9 in total

1.  Study of transactivating effect of pre-S2 protein of hepatitis B virus and cloning of genes transactivated by pre-S2 protein with suppression subtractive hybridization.

Authors:  Dong Ji; Jun Cheng; Guo-Feng Chen; Yan Liu; Lin Wang; Jiang Guo
Journal:  World J Gastroenterol       Date:  2005-09-21       Impact factor: 5.742

2.  Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c.

Authors:  Mitsuhiro Watanabe; Sander M Houten; Li Wang; Antonio Moschetta; David J Mangelsdorf; Richard A Heyman; David D Moore; Johan Auwerx
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

3.  Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype.

Authors:  Clive R Pullinger; Celeste Eng; Gerald Salen; Sarah Shefer; Ashok K Batta; Sandra K Erickson; Andrea Verhagen; Christopher R Rivera; Sean J Mulvihill; Mary J Malloy; John P Kane
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

4.  Transactivating effect of hepatitis C virus core protein: a suppression subtractive hybridization study.

Authors:  Min Liu; Yan Liu; Jun Cheng; Shu-Lin Zhang; Lin Wang; Qing Shao; Jian Zhang; Qian Yang
Journal:  World J Gastroenterol       Date:  2004-06-15       Impact factor: 5.742

5.  Bile acid metabolites in serum: intraindividual variation and associations with coronary heart disease, metabolic syndrome and diabetes mellitus.

Authors:  Carine Steiner; Alaa Othman; Christoph H Saely; Philipp Rein; Heinz Drexel; Arnold von Eckardstein; Katharina M Rentsch
Journal:  PLoS One       Date:  2011-11-14       Impact factor: 3.240

6.  Differential modulation of cellular death and survival pathways by conjugated bile acids.

Authors:  E C Torchia; A Stolz; L B Agellon
Journal:  BMC Biochem       Date:  2001-10-15       Impact factor: 4.059

7.  A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model.

Authors:  François-Pierre J Martin; Marc-Emmanuel Dumas; Yulan Wang; Cristina Legido-Quigley; Ivan K S Yap; Huiru Tang; Séverine Zirah; Gerard M Murphy; Olivier Cloarec; John C Lindon; Norbert Sprenger; Laurent B Fay; Sunil Kochhar; Peter van Bladeren; Elaine Holmes; Jeremy K Nicholson
Journal:  Mol Syst Biol       Date:  2007-05-22       Impact factor: 11.429

8.  Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model.

Authors:  Francois-Pierre J Martin; Yulan Wang; Norbert Sprenger; Ivan K S Yap; Torbjörn Lundstedt; Per Lek; Serge Rezzi; Ziad Ramadan; Peter van Bladeren; Laurent B Fay; Sunil Kochhar; John C Lindon; Elaine Holmes; Jeremy K Nicholson
Journal:  Mol Syst Biol       Date:  2008-01-15       Impact factor: 11.429

9.  Serum metabolomic signatures discriminate early liver inflammation and fibrosis stages in patients with chronic hepatitis B.

Authors:  Haijun Huang; Zeyu Sun; Hongying Pan; Meijuan Chen; Yongxi Tong; Jiajie Zhang; Deying Chen; Xiaoling Su; Lanjuan Li
Journal:  Sci Rep       Date:  2016-08-08       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.